Mediclinic announced the appointment of Dame Inga Beale as an independent non-executive director and Chair Designate with effect from 26 March 2020. Following a handover period, Dame Inga will succeed Dr. Edwin Hertzog as Chair upon his retirement at the conclusion of the Company's annual general meeting on 22 July 2020. She currently serves as an independent member of the global strategy board of Clyde & Co LLP and as an independent non-executive director on the boards of Crawford & Company and London First. Dame Inga has also been appointed as a member of the Nomination Committee with effect from 26 March 2020.